The global MRI-compatible IV infusion pump systems market is on an impressive growth trajectory, with forecasts indicating a substantial rise to USD 580.3 million by 2032, up from USD 234.8 million in 2022. This growth represents a robust Compound Annual Growth Rate (CAGR) of 9.5% during the forecast period, driven by the increasing adoption of these advanced drug delivery systems over conventional infusion pumps.
Key Trends Driving Market Growth
One of the primary factors contributing to this market surge is the growing awareness of the advantages that MRI-compatible IV infusion pump systems offer. Healthcare providers are increasingly shifting their preference towards these systems due to their enhanced safety features and reliability in drug delivery. As hospitals prioritize patient safety and efficacy, the demand for advanced infusion technology is on the rise.
The market is also influenced by ongoing innovations in device engineering that address clinical and device-based limitations. These advancements aim to enhance patient safety and ensure seamless integration of infusion pumps into healthcare settings. Notably, the prevalence of medication errors in infusion-based therapies is prompting a shift towards advanced infusion pumps, which are equipped with features designed to mitigate these risks.
Advanced Safety Features Enhance Patient Care
MRI-compatible IV infusion pump systems incorporate a variety of features that enhance patient safety. A large, high-contrast color touch screen provides healthcare professionals with critical information about the medication being administered, including concentration, dosage, and infusion rate. Additionally, these pumps are integrated with drug libraries that set limits on medication delivery, further minimizing the risk of errors.
Innovative solutions in this sector promote both objective and subjective patient safety, ultimately elevating the overall quality of healthcare. As healthcare facilities continue to prioritize patient safety and efficacy in treatment, the MRI-compatible IV infusion pump systems market is expected to experience lucrative growth.
With a strong outlook for the coming years, the MRI-compatible IV infusion pump systems market is poised for substantial expansion. As healthcare providers increasingly recognize the benefits of these advanced systems, the shift away from conventional infusion pumps will drive the market towards a promising future.
Expanding Market Need: Access Our Full Report for In-Depth Analysis and Trends!
Key Takeaways from the MRI-Compatible IV Infusion Pump Market Analysis:
Market Dominance and Growth:
- The United States holds the largest market share (70.1% in 2021), driven by factors like increasing chronic disease incidence, FDA-approved devices, and favorable reimbursement policies.
- The global market is expected to expand at a significant CAGR of 13.6% during the forecast period.
Driving Factors:
- Chronic Diseases: The rising prevalence of chronic diseases is a primary driver of market growth.
- Hospital Admissions: Increased hospitalizations and surgical procedures contribute to demand.
- Advanced Technology: The availability of FDA-approved devices and innovative features like portability drive market adoption.
- Reimbursement Policies: Favorable reimbursement policies in the United States support market growth.
Regional Trends:
- Germany: The market is growing due to medical tourism, R&D efforts, insurance industry growth, and demand for smart infusion pumps.
- China: The market is expanding due to a growing geriatric population, chronic disease burden, increased hospitalizations, and healthcare industry development.
Market Segmentation:
- Device Systems: This segment holds the largest market share (90.1% in 2021) due to increasing usage in healthcare facilities and portability benefits.
- Hospitals: Hospitals account for the largest revenue share (63.7% in 2021), driven by increased hospitalizations and surgical procedures.
Competitive Landscape:
Key players in the MRI-compatible IV infusion pump systems market are implementing strategies that include launching new products, obtaining device patents and licenses, and securing regulatory approvals for marketing.
Notable developments in the market include:
- In July 2020, IRADIMED CORPORATION announced that the US Patent and Trademark Office granted a patent related to the wireless remote control of IV infusion pumps, further enhancing its earlier claims.
- In April 2020, B. Braun Medical Inc. received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its Perfusor Space Syringe Infusion Pump, Infusomat Space Volumetric Infusion Pump, and Outlook ES Pump systems. This authorization allows these devices to be used for treating patients of all ages with confirmed or suspected COVID-19, while minimizing healthcare professionals’ exposure during the pandemic.
Key Companies Profiled:
- iRadimed Corporation
- B.Braun Melsungen AG
- Fresenius Kabi AG
- Smiths Medical (Smiths Group plc.)
- Arcomed AG
- Becton, Dickinson Company (Carefusion)
- Baxter International Inc.
Key Market Segments Covered in MRI-Compatible IV Infusion Pump Systems Industry Research:
By Product:
- Device System
- Non-magnetic pump systems
- Magnetic pump system with shielding
- Tubing and Disposables
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Diagnostics Imaging Centers
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
